EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer

Shinjini Ganguly, Zaeem Lone, Andrew Muskara, Jarrell Imamura, Aimalie Hardaway, Mona Patel, Mike Berk, Timothy D Smile, Elai Davicioni, Kevin L Stephans, Jay Ciezki, Christopher J Weight und 7 weitere

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci165718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Shinjini Ganguly und 18 weiteren Autor:innen. Beteiligte Einrichtung: Translational Hematology and Oncology Research. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. Department of Defense, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantHumansMaleAndrogen AntagonistsAndrogensDNAGenotypeHydroxysteroid DehydrogenasesMultienzyme ComplexesReceptors, AndrogenProgesterone ReductaseSteroid Isomerases

Stichwörter der Autor:innen

EndocrinologyProstate cancerRadiation therapySex hormonesTherapeutics

Substanzen

Androgen AntagonistsAndrogensDNAHydroxysteroid DehydrogenasesMultienzyme ComplexesReceptors, Androgen3 beta-hydroxysteroid oxidoreductase-delta(5) 3-ketosteroid isomeraseProgesterone ReductaseSteroid Isomerases

Autor:innen und Institutionen

  • Translational Hematology and Oncology Research.
  • Thermo Fisher Scientific, Ann Arbor, Michigan, USA.
  • Department of Cancer Biology, Lerner Research Institute.
  • Department of Radiation Oncology, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Veracyte Inc., San Francisco, California, USA.
  • Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense
  • American Cancer Society
  • National Cancer Institute
  • VeloSano Foundation

Zitieren

APA

Ganguly, S., Lone, Z., Muskara, A., Imamura, J., Hardaway, A., Patel, M., Berk, M., Smile, T. D., Davicioni, E., Stephans, K. L., Ciezki, J., Weight, C. J., Gupta, S., Reddy, C. A., Tendulkar, R. D., Chakraborty, A. A., Klein, E. A., Sharifi, N., & Mian, O. Y. (2023). Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci165718

Vancouver

Ganguly S, Lone Z, Muskara A, Imamura J, Hardaway A, Patel M, et al. Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer. Journal of Clinical Investigation. 2023. doi:10.1172/jci165718

BibTeX
@article{Ganguly2023,
  author = {Ganguly, Shinjini and Lone, Zaeem and Muskara, Andrew and Imamura, Jarrell and Hardaway, Aimalie and Patel, Mona and Berk, Mike and Smile, Timothy D and Davicioni, Elai and Stephans, Kevin L and Ciezki, Jay and Weight, Christopher J and Gupta, Shilpa and Reddy, Chandana A and Tendulkar, Rahul D and Chakraborty, Abhishek A and Klein, Eric A and Sharifi, Nima and Mian, Omar Y},
  title = {Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci165718}
}
Kostenlos starten →